Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04687475 · ClinicalTrials.gov registry record · NA

Implementation of a Clinical Tool to Improve Waitlist Mortality in Patients With Cystic Fibrosis

A NA study of Cystic Fibrosis and Lung Transplant; Complications, sponsored by The Cleveland Clinic.

Active
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT04687475: Active NA study of Cystic Fibrosis and Lung Transplant; Complications, sponsored by The Cleveland Clinic.

NCT04687475 is a NA study of Cystic Fibrosis and Lung Transplant; Complications that is active but no longer recruiting, run by The Cleveland Clinic. The registered enrollment target is 10 participants, below the 179-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04687475, a NA study of Cystic Fibrosis and Lung Transplant; Complications, is active but no longer recruiting, sponsored by The Cleveland Clinic.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

Implementation of a Clinical Tool to Improve Waitlist Mortality in Patients With Cystic Fibrosis

Primary Outcome

Change in LAS value at the first clinic visit triggered by the clinical tool

Interventions

  • OTHER Clinical Tool (Mobile Spirometry and Survey)

Study Locations (1)

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2020-04-20
Est. Completion 2026-06-01
Phase NA
The Cleveland Clinic

688 total trials

What the registry record for NCT04687475 still lists

NCT04687475 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 179-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (94% lower).

The record links to 2 conditions, with Cystic Fibrosis appearing as the primary indexed condition, and to 1 intervention - of which Clinical Tool (Mobile Spirometry and Survey) is the first listed.

NCT04687475 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT04687475 about?

NCT04687475 is a clinical study titled "Implementation of a Clinical Tool to Improve Waitlist Mortality in Patients With Cystic Fibrosis". Implementation of a Clinical Tool to Improve Waitlist Mortality in Patients With Cystic Fibrosis

What is the current status of trial NCT04687475?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2020-04-20. Estimated completion is 2026-06-01.

What conditions does trial NCT04687475 study?

This clinical trial studies the following conditions: Cystic Fibrosis, Lung Transplant; Complications.

What interventions are being tested in trial NCT04687475?

The interventions under investigation include: Clinical Tool (Mobile Spirometry and Survey) (OTHER).

Who is sponsoring clinical trial NCT04687475?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04687475 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cystic Fibrosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04687475's enrollment target sits among peer trials

10 159th of 169 higher than 9 of 169 other Cystic Fibrosis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cystic Fibrosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04687475, the US trial registry maintained by the National Library of Medicine. NCT04687475 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.